34 related articles for article (PubMed ID: 10399167)
1. Phosphohistone-H3 and Ki67: Useful Markers in Differentiating Dermatofibroma From Dermatofibrosarcoma Protuberans and Atypical Fibrohistiocytic Lesions.
Agarwal A; Gopinath A; Tetzlaff MT; Prieto VG
Am J Dermatopathol; 2017 Jul; 39(7):504-507. PubMed ID: 28609344
[TBL] [Abstract][Full Text] [Related]
2. Microphthalmia-associated transcription factor (MiTF): Promiscuous staining patterns in fibrohistiocytic lesions is a potential pitfall.
Mohanty SK; Sharma S; Pradhan D; Kandukuri SR; Farahani N; Barry C; Wu JM; Frishberg D; Balzer B
Pathol Res Pract; 2018 Jun; 214(6):821-825. PubMed ID: 29773427
[TBL] [Abstract][Full Text] [Related]
3. TLE1 expression fails to distinguish between synovial sarcoma, atypical fibroxanthoma, and dermatofibrosarcoma protuberans.
Pukhalskaya T; Smoller BR
J Cutan Pathol; 2020 Feb; 47(2):135-138. PubMed ID: 31614009
[TBL] [Abstract][Full Text] [Related]
4. The Immunological Roles of Periostin/Tumor-Associated Macrophage Axis in Development of Dermatofibrosarcoma Protuberans.
Fujimura T; Kakizaki A; Sato Y; Tanita K; Furudate S; Aiba S
Anticancer Res; 2017 Jun; 37(6):2867-2873. PubMed ID: 28551623
[TBL] [Abstract][Full Text] [Related]
5. The Role of CD34 and D2-40 in the Differentiation of Dermatofibroma and Dermatofibrosarcoma Protuberans.
Sadullahoğlu C; Dere Y; Atasever TR; Öztop MT; Karaaslan Ö
Turk Patoloji Derg; 2017; 1(1):223-227. PubMed ID: 28832078
[TBL] [Abstract][Full Text] [Related]
6. ETS-related Gene (ERG) is Differentially Expressed in Dermatofibroma (Fibrous Histiocytoma) as Compared With Dermatofibrosarcoma Protuberans and Hypertrophic Scars: A Pilot Immunohistochemical Study.
Hengy M; Veenstra J; Perry K; Ozog DM; Friedman BJ
Appl Immunohistochem Mol Morphol; 2022 Jul; 30(6):453-458. PubMed ID: 35510745
[TBL] [Abstract][Full Text] [Related]
7. Comparative expression profile of CD10 and cyclin D1 in cutaneous histiocytofibroma and dermatofibrosarcoma.
Kouki N; Ben Rejeb S; Cherif I; Ghozzi A; Chelly I; Bellil K; Haouet S
J Immunoassay Immunochem; 2021 Jul; 42(4):347-358. PubMed ID: 33444077
[TBL] [Abstract][Full Text] [Related]
8. Expression of proton-sensing G-protein-coupled receptors in selected skin tumors.
Nassios A; Wallner S; Haferkamp S; Klingelhöffer C; Brochhausen C; Schreml S
Exp Dermatol; 2019 Jan; 28(1):66-71. PubMed ID: 30339292
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of ERG immunostaining in dermatofibroma.
Yamada Y; Ichiki T; Susuki Y; Yamada-Nozaki Y; Tateishi Y; Furue M; Oda Y
J Clin Pathol; 2023 Aug; 76(8):536-540. PubMed ID: 35318257
[TBL] [Abstract][Full Text] [Related]
10. A study of collagen refractility in dermatofibroma and dermatofibrosarcoma protuberans using diffractive microscopy.
Brailsford C; Khamdan F; Dirr MA; Sagut P; Nietert PJ; Elston D
J Cutan Pathol; 2024 Apr; 51(4):306-310. PubMed ID: 38124386
[TBL] [Abstract][Full Text] [Related]
11. Hormone receptors analysis in Chinese patients with dermatofibrosarcoma protuberans.
Meng T; Shi XH; Wu SF; Luo YF; Wang XJ; Long X
J Surg Oncol; 2018 Jul; 118(1):157-166. PubMed ID: 29878374
[TBL] [Abstract][Full Text] [Related]
12. Dermatofibroma Versus Dermatofibrosarcoma Protuberans: A Nuclear Morphology Study.
Khamdan F; Brailsford C; Dirr MA; Sagut P; Nietert PJ; Elston D
Am J Dermatopathol; 2023 Sep; 45(9):631-634. PubMed ID: 37625803
[TBL] [Abstract][Full Text] [Related]
13. A Tete - a - tete of benign, borderline and malignant fibrohistiocytic tumor.
M V R; P P; G M S
Iran J Pathol; 2016; 11(3):286-290. PubMed ID: 27799980
[TBL] [Abstract][Full Text] [Related]
14. Identification of leukocyte-specific protein 1-positive cells: a clue to the cell of origin and a marker for the diagnosis of dermatofibroma.
Jin SY; Choi JS; Choi YL; Choi YL; Kim DH; Lee SH
Ann Dermatol; 2015 Apr; 27(2):157-62. PubMed ID: 25834354
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical localization of the NM23 protein in salivary gland neoplasms with distinct biological behavior.
do Nascimento KC; de Faria PR; Dib LL; Ferreira de Aguiar MC; Cardoso SV; Chen J; Loyola AM
Virchows Arch; 2006 Dec; 449(6):660-6. PubMed ID: 17091257
[TBL] [Abstract][Full Text] [Related]
16. Proteomic comparison of prostate cancer cell lines LNCaP-FGC and LNCaP-r reveals heatshock protein 60 as a marker for prostate malignancy.
Johansson B; Pourian MR; Chuan YC; Byman I; Bergh A; Pang ST; Norstedt G; Bergman T; Pousette A
Prostate; 2006 Sep; 66(12):1235-44. PubMed ID: 16705742
[TBL] [Abstract][Full Text] [Related]
17. nm23 protein expression and p53 immunoreactivity in cutaneous fibrohistiocytic tumors.
Lee CS; Clarke RA; Tran KT; Kearsley JH; Chou ST
Pathology; 1999 May; 31(2):123-6. PubMed ID: 10399167
[TBL] [Abstract][Full Text] [Related]
18. p53 protein immunoreactivity in fibrohistiocytic tumors of the skin.
Lee CS; Chou ST
Pathology; 1998 Aug; 30(3):272-5. PubMed ID: 9770192
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity.
Li N; McNiff J; Hui P; Manfioletti G; Tallini G
Am J Dermatopathol; 2004 Aug; 26(4):267-72. PubMed ID: 15249855
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
